Enlivex Therapeutics (ENLV) announced the closing of the Company’s previously announced $212,000,000 private investment. Enlivex intends to use net proceeds from private placement to implement the first RAIN prediction markets token treasury strategy, while continuing its focus on the Company’s core business operations.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENLV:
- 3 Penny Stocks to Watch Now, 11/25/25
- Crypto Currents: Upbit plans IPO, Revolut hits $75B valuation
- Enlivex Reports Positive Six-Month Data for Knee Osteoarthritis Trial
- Enlivex Completes Private Placement to Fund Digital Asset Strategy
- Enlivex Therapeutics downgraded to Hold from Buy at D. Boral Capital